|
ZNF836 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.00949999999267E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.751210E-04 |
| Normal-vs-Stage2 |
1.443900E-03 |
| Normal-vs-Stage3 |
2.302300E-03 |
| Normal-vs-Stage4 |
4.175600E-03 |
| Stage1-vs-Stage2 |
4.880400E-01 |
| Stage1-vs-Stage3 |
8.475200E-01 |
| Stage1-vs-Stage4 |
9.980200E-01 |
| Stage2-vs-Stage3 |
4.640600E-01 |
| Stage2-vs-Stage4 |
5.598200E-01 |
| Stage3-vs-Stage4 |
8.959800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.163200E-04 |
| Normal-vs-AfricanAmerican |
1.900760E-01 |
| Normal-vs-Asian |
3.333800E-02 |
| Caucasian-vs-AfricanAmerican |
3.024000E-01 |
| Caucasian-vs-Asian |
5.550200E-01 |
| AfricanAmerican-vs-Asian |
6.337600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.077500E-03 |
| Normal-vs-Female |
2.10589999999344E-05 |
| Male-vs-Female |
1.251580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.953700E-04 |
| Normal-vs-Age(41-60Yrs) |
9.95190000000479E-05 |
| Normal-vs-Age(61-80Yrs) |
1.695880E-03 |
| Normal-vs-Age(81-100Yrs) |
1.463430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.692000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.944400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.344200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.298800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.893600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.153000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.550400E-01 |
| Classical-VS-Follicular |
1.59881999999278E-05 |
| Classical-VS-Other |
2.630800E-01 |
| Classical-VS-Normal |
3.937200E-03 |
| Tall-VS-Follicular |
2.818100E-02 |
| Tall-VS-Other |
4.220400E-01 |
| Tall-VS-Normal |
3.777600E-02 |
| Follicular-VS-Other |
7.385400E-01 |
| Follicular-VS-Normal |
2.01910000052763E-07 |
| Other-VS-Normal |
6.464400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.62180000000168E-05 |
| Normal-vs-N1 |
5.235500E-04 |
| N0-vs-N1 |
5.932000E-01 |
|
|
